Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  251,879 results for ""INTERLEUKIN-2""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma.

  • Authors : Albertini MR; University of Wisconsin Carbone Cancer Center.; Departments of, Medicine.

Subjects: Melanoma*/Melanoma*/Melanoma*/radiotherapy ; Melanoma*/Melanoma*/Melanoma*/immunology ; Melanoma*/Melanoma*/Melanoma*/pathology

  • Source: Melanoma research [Melanoma Res] 2024 Aug 01; Vol. 34 (4), pp. 307-318. Date of Electronic Publication: 2024 May 20.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Low-dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?

  • Authors : Amini L; Berlin Center for Advanced Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health - Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Subjects: T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/immunology ; T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/drug effects ; Interleukin-2*/Interleukin-2*/Interleukin-2*/administration & dosage

  • Source: Transplantation [Transplantation] 2024 Jul 01; Vol. 108 (7), pp. 1492-1508. Date of Electronic Publication: 2024 Jan 31.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Soluble expression of recombinant human interleukin-2 in Escherichia coli and its facile production.

  • Authors : Zhang M; Department of Biopharmaceutics, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.; Zheng Y

Subjects: Escherichia coli*/Escherichia coli*/Escherichia coli*/genetics ; Escherichia coli*/Escherichia coli*/Escherichia coli*/metabolism ; Interleukin-2*/Interleukin-2*/Interleukin-2*/genetics

  • Source: Protein expression and purification [Protein Expr Purif] 2024 Sep; Vol. 221, pp. 106507. Date of Electronic Publication: 2024 May 20.Publisher: Academic Press Country of Publication: United States NLM ID: 9101496 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery.

  • Authors : Li M; Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, 215123, China.; Liu N

Subjects: Probiotics*/Probiotics*/Probiotics*/administration & dosage ; Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/therapy ; Interleukin-2*/Interleukin-2*/Interleukin-2*/metabolism

  • Source: Biomaterials [Biomaterials] 2024 Sep; Vol. 309, pp. 122584. Date of Electronic Publication: 2024 May 08.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8100316 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes.

  • Authors : Luo Z; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. .; Mejia-Cordova M

Subjects: Interleukin-2* ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/immunology

  • Source: Endocrine [Endocrine] 2024 Aug; Vol. 85 (2), pp. 626-637. Date of Electronic Publication: 2024 Feb 29.Publisher: Humana Press Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™.

  • Authors : Georgiev T; R&D Department, Philochem AG, Libernstrasse 3, CH-8112, Otelfingen, ZH, Switzerland.; Principi L

Subjects: Interleukin-2*; Animals ; Mice

  • Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (8), pp. 2332-2337. Date of Electronic Publication: 2024 Apr 02.Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Low-Dose Interleukin-2 Reverses Traumatic Brain Injury-Induced Cognitive Deficit and Pain in a Murine Model.

  • Authors : Czerpaniak K; Department of Anesthesiology and Washington University Pain Center, Washington University in St Louis School of Medicine, St Louis, MO, USA.; do Nascimento LF

Subjects: Interleukin-2* ; Cognitive Dysfunction*/Cognitive Dysfunction*/Cognitive Dysfunction*/etiology ; Cognitive Dysfunction*/Cognitive Dysfunction*/Cognitive Dysfunction*/drug therapy

  • Source: Annals of neurology [Ann Neurol] 2024 Sep; Vol. 96 (3), pp. 508-525. Date of Electronic Publication: 2024 Jul 20.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosis.

  • Authors : Alarcan H; Service de Biochimie et Biologie Moléculaire, CHRU Bretonneau, Tours, France.; UMR 1253 iBrain, Université de Tours, Inserm, Tours, France.

Subjects: Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/drug therapy ; Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/metabolism ; Interleukin-2*/Interleukin-2*/Interleukin-2*/administration & dosage

  • Source: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2024 Jun; Vol. 1536 (1), pp. 82-91. Date of Electronic Publication: 2024 May 21.Publisher: New York Academy of Sciences Country of Publication: United States NLM ID: 7506858 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology.

  • Authors : Sommer C; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany.; Jacob S

Subjects: Interleukin-2*/Interleukin-2*/Interleukin-2*/immunology ; Interleukin-2*/Interleukin-2*/Interleukin-2*/genetics ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology

  • Source: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2024 Sep; Vol. 266, pp. 110288. Date of Electronic Publication: 2024 Jun 29.Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.

  • Authors : Shouse AN; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.; LaPorte KM

Subjects: Interleukin-2*/Interleukin-2*/Interleukin-2*/metabolism ; Neoplasms*; Humans

  • Source: Immunity [Immunity] 2024 Mar 12; Vol. 57 (3), pp. 414-428.Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Internet ISSN: 1097-4180

Record details

Read More Add to Saved list
×
  • 1-10 of  251,879 results for ""INTERLEUKIN-2""